CME: Preventing group B streptococcal infections with targeted therapy

March 1, 2001

Since the CDC recommendations have been put into practice, we've seen a dramatic decline in early-onset neonatal GBS infections. But an expert in the field discusses several unresolved issues and emphasizes the need for continued vigilance to keep the disease under control.